{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:31:54Z","timestamp":1784291514081,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Medullary thyroid carcinoma is a malignant uncommon and aggressive tumour of the parafollicular C cells. In about 75% of cases it is sporadic while, in case of RET mutation, it is associated to multiple endocrine neoplasia type 2 (25% of cases). The biochemical features of medullary thyroid carcinoma include the production of calcitonin and carcinoembryogenic antigen. The above-mentioned features are useful in the diagnostic process as well as in the follow up and in the prognostication of the disease. Even if calcitonin elevation is strongly associated to MTC, it can also be found increased in many pathological different conditions as pregnancy, lactation, C-cells hyperplasia, autoimmune thyroiditis, end stage renal disease, lung and prostate cancer and several neuroendocrine tumours. Major medullary thyroid tumours are usually connected to high doses of circulating calcitonin, in fact non-secretory variants have hardly been described.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We herein report the case of a 59\u2009years old male, who had undergone total thyroidectomy for multinodular goiter with negative preoperative calcitonin, showing medullary thyroid carcinoma at definitive pathology. To the best of our knowledge, this is the first case documenting a non-secretory medullary thyroid carcinoma, with double negative markers at the time of diagnosis and at the relapse.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A Literature review underlining pathological hypothesis, differential diagnosis and alternative and innovative biomarkers to identify non-secretory medullary thyroid carcinoma was carried out.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-019-0435-7","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T11:07:21Z","timestamp":1571224041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-2960","authenticated-orcid":false,"given":"Claudio","family":"Gambardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Offi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Clarizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Maria","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Di Crescenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Cangiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Candela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Docimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"435_CR1","doi-asserted-by":"publisher","unstructured":"Docimo G, Tolone S, Conzo G, Limongelli P, Del Genio G, Parmeggiani D, De Palma M, Lupone G, Avenia N, Lucchini R, Monacelli M, Gulotta G, Scerrino G, Pasquali D, Bellastella G, Esposito K, De Bellis A, Pezzolla A, Ruggiero R, Docimo L. A Gelatin-Thrombin Matrix Topical Hemostatic Agent (Floseal) in Combination With Harmonic Scalpel Is Effective in Patients Undergoing Total Thyroidectomy: A Prospective, Multicenter, Single-Blind, Randomized Controlled Trial. Surg Innov. 2016. \n                    https:\/\/doi.org\/10.1177\/1553350615596638\n                    \n                  .","DOI":"10.1177\/1553350615596638"},{"key":"435_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7819-4-97","volume":"4","author":"M Sand","year":"2006","unstructured":"Sand M, Gelos M, Sand D, Bechara FG, Bonhag G, Welsing E, Mann B. Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol. 2006;4:97.","journal-title":"World J Surg Oncol"},{"key":"435_CR3","doi-asserted-by":"publisher","unstructured":"Conzo G, Docimo G, Pasquali D, Mauriello C, Gambardella C, Esposito D, Tartaglia E, Della Pietra C, Napolitano S, Rizzuto A, Santini L. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. BMC Surg. 2013; doi: \n                    https:\/\/doi.org\/10.1186\/1471-2482-13-S2-S3\n                    \n                  .","DOI":"10.1186\/1471-2482-13-S2-S3"},{"issue":"6","key":"435_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787\u2013803.","journal-title":"Eur J Endocrinol"},{"key":"435_CR5","doi-asserted-by":"publisher","unstructured":"Conzo G, Mauriello C, Docimo G, Gambardella C, Thomas G, Cavallo F, Tartaglia E, Napolitano S, Varriale R, Rossetti G, Fei L, Santini L. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery. Int J Surg. 2014. \n                    https:\/\/doi.org\/10.1016\/j.ijsu.2014.05.010\n                    \n                  .","DOI":"10.1016\/j.ijsu.2014.05.010"},{"key":"435_CR6","doi-asserted-by":"publisher","unstructured":"Sam\u00e0 MT, Rossetto Giaccherino R, Gallo M, Felicetti F, Maletta F, Bonelli N, Piovesan A, Palestini N, Ghigo E, Arvat E. Clinical challenges with calcitonin-negative medullary thyroid carcinoma. J Cancer Res Clin Oncol. 2016. \n                    https:\/\/doi.org\/10.1007\/s00432-016-2169-5\n                    \n                  .","DOI":"10.1007\/s00432-016-2169-5"},{"issue":"7","key":"435_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1056\/NEJM198902163200707","volume":"320","author":"RE Sobol","year":"1989","unstructured":"Sobol RE, Memoli V, Deftos LJ. Hormone-negative, chromogranin A-positive endocrine tumors. N Engl J Med. 1989;320(7):444\u20137.","journal-title":"N Engl J Med"},{"key":"435_CR8","doi-asserted-by":"publisher","unstructured":"Sparano C, Parenti G, Cilotti A, Bencini L, Calistri M, Mannucci E, Biagini C, Vezzosi V, Mannelli M, Forti G, Petrone L. Clinical impact of the new SIAPEC-IAP classification on the indeterminate category of thyroid nodules. J Endocrinol Investig. 2018. \n                    https:\/\/doi.org\/10.1007\/s40618-018-0871-7\n                    \n                  .","DOI":"10.1007\/s40618-018-0871-7"},{"key":"435_CR9","doi-asserted-by":"publisher","unstructured":"Alapat DV, Ain KB, Sloan DA, Monaghan KG, Karabakhtsian RG. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma. Endocrine. 2011. \n                    https:\/\/doi.org\/10.1007\/s12020-010-9433-2\n                    \n                  .","DOI":"10.1007\/s12020-010-9433-2"},{"key":"435_CR10","doi-asserted-by":"publisher","unstructured":"Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ 3rd, Ganly I, Hodak SP, Kebebew E, Patel KN, Shaha A, Steward DL, Tufano RP, Wiseman SM, Carty SE, American Thyroid Association Surgical Affairs Committee. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid. 2015. \n                    https:\/\/doi.org\/10.1089\/thy.2014.0502\n                    \n                  .","DOI":"10.1089\/thy.2014.0502"},{"key":"435_CR11","doi-asserted-by":"publisher","unstructured":"Ismi O, Arpaci RB, Berkesoglu M, Dag A, Sezer E, Bal KK, Vay\u0131so\u011flu Y. Calcitonin-negative neuroendocrine tumor of thyroid gland mimicking anaplastic carcinoma: an unusual entity. Gland Surg. 2015. \n                    https:\/\/doi.org\/10.3978\/j.issn.2227-684X.2015.01.02\n                    \n                  .","DOI":"10.3978\/j.issn.2227-684X.2015.01.02"},{"issue":"1","key":"435_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/jcem-19-1-152","volume":"19","author":"JB Hazard","year":"1959","unstructured":"Hazard JB, Hawk WA, Crile G Jr. Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab. 1959;19(1):152\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"435_CR13","doi-asserted-by":"publisher","unstructured":"Trimboli P, Cremonini N, Ceriani L, Saggiorato E, Guidobaldi L, Romanelli F, Ventura C, Laurenti O, Messuti I, Solaroli E, Madaio R, Bongiovanni M, Orlandi F, Crescenzi A, Valabrega S, Giovanella L. Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study. Clin Endocrinol. 2014. \n                    https:\/\/doi.org\/10.1111\/cen.12234\n                    \n                  .","DOI":"10.1111\/cen.12234"},{"key":"435_CR14","doi-asserted-by":"publisher","unstructured":"Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S, De Leo S, Sarais C, Cacciatore C, Manfredi GI, Verga U, Iacobone M, De Pasquale L, Pelizzo MR, Vicentini L, Persani L, Fugazzola L. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. J Clin Endocrinol Metab. 2014. \n                    https:\/\/doi.org\/10.1210\/jc.2013-4088\n                    \n                  .","DOI":"10.1210\/jc.2013-4088"},{"key":"435_CR15","doi-asserted-by":"publisher","unstructured":"Machens A, Lorenz K, Dralle H. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. J Clin Endocrinol Metab. 2014. \n                    https:\/\/doi.org\/10.1210\/jc.2014-1278\n                    \n                  .","DOI":"10.1210\/jc.2014-1278"},{"issue":"1","key":"435_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1210\/jc.2003-030550","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F. Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab. 2004;89(1):163\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"435_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/jso.20269","volume":"91","author":"MJ Bugalho","year":"2005","unstructured":"Bugalho MJ, Santos JR, Sobrinho L. Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol. 2005;91(1):56\u201360.","journal-title":"J Surg Oncol"},{"key":"435_CR18","doi-asserted-by":"publisher","unstructured":"Liu Y, Yuan L, Yang D, Jin Y. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: a case report and review of the literatures. Diagn Cytopathol. 2018. \n                    https:\/\/doi.org\/10.1002\/dc.23924\n                    \n                  .","DOI":"10.1002\/dc.23924"},{"key":"435_CR19","doi-asserted-by":"publisher","unstructured":"Conzo G, Tartaglia E, Avenia N, Cal\u00f2 PG, de Bellis A, Esposito K, Gambardella C, Iorio S, Pasquali D, Santini L, Sinisi MA, Sinisi AA, Testini M, Polistena A, Bellastella G. Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends. World J Surg Oncol. 2016. \n                    https:\/\/doi.org\/10.1186\/s12957-016-0879-4\n                    \n                  .","DOI":"10.1186\/s12957-016-0879-4"},{"key":"435_CR20","doi-asserted-by":"publisher","unstructured":"Frank-Raue K, Machens A, Leidig-Bruckner G, Rondot S, Haag C, Schulze E, Lorenz A, Kreissl MC, Dralle H, Raue F, Schmid KW. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma. Thyroid. 2013;doi: \n                    https:\/\/doi.org\/10.1089\/thy.2012.0236\n                    \n                  .","DOI":"10.1089\/thy.2012.0236"},{"key":"435_CR21","doi-asserted-by":"publisher","unstructured":"Zhou Q, Yue S, Cheng Y, Jin J, Xu H. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin. Exp Toxicol Pathol. 2017. \n                    https:\/\/doi.org\/10.1016\/j.etp.2017.05.003\n                    \n                  .","DOI":"10.1016\/j.etp.2017.05.003"},{"key":"435_CR22","doi-asserted-by":"publisher","unstructured":"Chernyavsky VS, Farghani S, Davidov T, Ma L, Barnard N, Amorosa LF, Trooskin SZ. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity. Thyroid. 2011. \n                    https:\/\/doi.org\/10.1089\/thy.2010.0299\n                    \n                  .","DOI":"10.1089\/thy.2010.0299"},{"issue":"5","key":"435_CR23","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","volume":"88","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer. 2000;88(5):1139\u201348.","journal-title":"Cancer."},{"issue":"1\u20132","key":"435_CR24","first-page":"65","volume":"23","author":"KW Schmid","year":"1996","unstructured":"Schmid KW, Mesewinkel F, B\u00f6cker W. Hyalinizing trabecular adenoma of the thyroid--morphology and differential diagnosis. Acta Med Austriaca. 1996;23(1\u20132):65\u20138.","journal-title":"Acta Med Austriaca"},{"key":"435_CR25","doi-asserted-by":"publisher","unstructured":"Dora JM, Canalli MH, Capp C, Pu\u00f1ales MK, Vieira JG, Maia AL. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature. Thyroid. 2008. \n                    https:\/\/doi.org\/10.1089\/thy.2007.0231\n                    \n                  .","DOI":"10.1089\/thy.2007.0231"},{"issue":"2","key":"435_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/jc.2005-1429","volume":"91","author":"R Leboeuf","year":"2006","unstructured":"Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD. \"Hook effect\" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab. 2006;91(2):361\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"435_CR27","doi-asserted-by":"crossref","unstructured":"Schiettecatte J, Anckaert E, Smitz J. Interferences in Immunoassays. In: Chiu NHL, editor. Advances in Immunoassay Technology. Brussel: InTech; 2012. p. 45\u201362.","DOI":"10.5772\/35797"},{"issue":"10","key":"435_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1089\/thy.2000.10.919","volume":"10","author":"AH Redding","year":"2000","unstructured":"Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid. 2000;10(10):919\u201322.","journal-title":"Thyroid."},{"key":"435_CR29","doi-asserted-by":"publisher","unstructured":"Wang TS, Ocal IT, Sosa JA, Cox H, Roman S. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid. 2008. \n                    https:\/\/doi.org\/10.1089\/thy.2007.0413\n                    \n                  .","DOI":"10.1089\/thy.2007.0413"},{"issue":"2","key":"435_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/172460080802300212","volume":"23","author":"L Giovanella","year":"2008","unstructured":"Giovanella L, Crippa S, Cariani L. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers. Int J Biol Markers. 2008;23(2):129\u201331.","journal-title":"Int J Biol Markers"},{"key":"435_CR31","doi-asserted-by":"publisher","unstructured":"Brutsaert EF, Gersten AJ, Tassler AB, Surks MI. Medullary thyroid cancer with undetectable serum calcitonin. J Clin Endocrinol Metab. 2015. \n                    https:\/\/doi.org\/10.1210\/jc.2014-3095\n                    \n                  .","DOI":"10.1210\/jc.2014-3095"},{"key":"435_CR32","doi-asserted-by":"publisher","unstructured":"Nakazawa T, Cameselle-Teijeiro J, Vinagre J, Soares P, Rousseau E, Eloy C, Sobrinho-Sim\u00f5es M. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity. Int J Surg Pathol. 2014. \n                    https:\/\/doi.org\/10.1177\/1066896914525228\n                    \n                  .","DOI":"10.1177\/1066896914525228"},{"issue":"3","key":"435_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s004280050238","volume":"433","author":"KW Schmid","year":"1998","unstructured":"Schmid KW, Ensinger C. \"Atypical\" medullary thyroid carcinoma with little or no calcitonin expression. Virchows Arch. 1998;433(3):209\u201315.","journal-title":"Virchows Arch"},{"key":"435_CR34","first-page":"32A","volume":"181","author":"KW Schmid","year":"1997","unstructured":"Schmid KW. Calcitonin-free medullary thyroid carcinoma: evidence for a neuroendocrine thyroid carcinoma of thymic origin? J Pathol (Lond). 1997;181:32A.","journal-title":"J Pathol (Lond)"},{"key":"435_CR35","doi-asserted-by":"publisher","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG, American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015. \n                    https:\/\/doi.org\/10.1089\/thy.2014.0335\n                    \n                  .","DOI":"10.1089\/thy.2014.0335"},{"issue":"2","key":"435_CR36","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab. 2007;92(2):450\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"435_CR37","doi-asserted-by":"publisher","unstructured":"Trimboli P, Giovanella L. Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature. Clin Chem Lab Med. 2015. \n                    https:\/\/doi.org\/10.1515\/cclm-2015-0058\n                    \n                  .","DOI":"10.1515\/cclm-2015-0058"},{"key":"435_CR38","doi-asserted-by":"publisher","unstructured":"Parmer M, Milan S, Torabi A. Calcitonin-negative neuroendocrine tumor of the thyroid. Int J Surg Pathol. 2017. \n                    https:\/\/doi.org\/10.1177\/1066896916670989\n                    \n                  .","DOI":"10.1177\/1066896916670989"},{"issue":"6","key":"435_CR39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1089\/105072504323150813","volume":"14","author":"M Bockhorn","year":"2004","unstructured":"Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid. 2004;14(6):468\u201370.","journal-title":"Thyroid."},{"key":"435_CR40","doi-asserted-by":"publisher","unstructured":"Kim GY, Park CY, Cho CH, Park JS, Jung ED, Jeon EJ. A calcitonin-negative neuroendocrine tumor derived from follicular lesions of the thyroid. Endocrinol Metab (Seoul). 2015. \n                    https:\/\/doi.org\/10.3803\/EnM.2015.30.2.221\n                    \n                  .","DOI":"10.3803\/EnM.2015.30.2.221"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-019-0435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:15:17Z","timestamp":1602717317000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-019-0435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1186\/s12902-019-0435-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"28 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable, data retrospectively obtained by clinical record.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave written informed consent to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}